Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

Author
K. Suissa
S. Schneeweiss
A. Douros
H. Yin
E. Patorno
L. Azoulay
Keywords
All-cause mortality
Cardiovascular outcomes
Effect modifier
Hospitalization for heart failure
Major adverse cardiovascular events
obesity
Sodium-glucose cotransporter-2 inhibitors
Year of Publication
2022
Journal
Diabetes Res Clin Pract
Volume
192
Number of Pages
110094
ISBN Number
0168-8227
Accession Number
36167266
DOI
10.1016/j.diabres.2022.110094